Schizophrenia is characterised by widespread perceptual abnormalities ([@bb0020], [@bb0080], [@bb0090]). In particular, individuals with schizophrenia show problems with tasks requiring integration of spatiotemporally local stimulus elements into coherent context-sensitive percepts ([@bb0135], [@bb0155]). In the temporal domain, whilst local motion perception shows no impairment, integration of local elements into a global percept of motion is compromised in schizophrenia ([@bb0045]). This effect could be mediated by a general failure to effectively integrate signals across both space and time; this theory suggests that as well as global motion, global form processing may be impaired in schizophrenia (e.g. [@bb0095]). However, a recent comparison of form and motion perception using dot-patterns suggested a greater motion deficit than form perception deficit in schizophrenia ([@bb0015]), implying some dissociation between the two domains. In the present study we investigated this question by studying a naturalistic form-detection task in schizophrenia and healthy controls, and comparing performance on this task to performance on a standard motion integration task. The form-detection task assessed detection sensitivity for two natural object types---faces and flowers---thereby also testing the hypothesis that schizophrenia is associated with a specific face processing deficit ([@bb0050], [@bb0075], [@bb0160]). In addition, we also assessed individuals with bipolar affective disorder, to test the hypothesis that these patients experience patterns of visual deficits similar to those with schizophrenia ([@bb0025], [@bb0085]).

Participants were inpatients in an acute adult psychiatry inpatient unit in Melbourne, Australia, and were compared to age-matched healthy controls from the general population. Inpatients had a primary diagnosis of either a schizophrenia spectrum disorder (SSD; schizophrenia, schizoaffective disorder or schizophreniform disorder) or bipolar affective disorder. Diagnoses were made independently of investigators by a consultant psychiatrist and multidisciplinary clinical team using DSM-IV criteria. Exclusion criteria were intellectual disability, traumatic brain injury, stroke, or neurodegenerative disease. Additional exclusion criteria for healthy control participants were psychotropic medication or illicit substance use within two weeks of testing, or personal history of psychiatric illness. All participants had normal or corrected-to-normal vision. Participants gave informed consent, and research protocols were approved by Melbourne Health and University of Melbourne Human Research Ethics Committees. Participants\' IQ was estimated using the National Adult Reading Test (NART; [@bb0010], [@bb0055]), and handedness was assessed using the Edinburgh Handedness Inventory ([@bb0120]). Benzodiazepine doses were converted to diazepam equivalents, and antipsychotic doses were converted to chlorpromazine equivalents ([@bb0005], [@bb0165]). [Table 1](#t0005){ref-type="table"} presents summary demographic statistics.Table 1Participant demographic characteristics for form and motion tasks[⁎](#tf0005){ref-type="table-fn"}.Schizophrenia spectrum disorderBipolar affective disorderHealthy control*n* completing form task22[a](#tf0010){ref-type="table-fn"}11[b](#tf0015){ref-type="table-fn"}13*n* completing motion task14[c](#tf0020){ref-type="table-fn"}8[d](#tf0025){ref-type="table-fn"}35Gender (form)17 M, 5 F5 M, 6 F6 M, 7 FGender (motion)11 M, 3 F5 F, 3 M20 M, 15 FHandedness (form)21R, OL, 1A10R, 1 L13R, 0 L, 0AHandedness (motion)13R, 0 L, 1A8R, 0 L32R, 2 L, 1AAge \[SEM\] (form)38.91\[3.06\]40.45 \[3.80\]40.38 \[3.81\]Age \[SEM\] (motion)40.00 \[3.94\]41.75 \[4.67\]39.11 \[2.28\]IQ estimate[e](#tf0030){ref-type="table-fn"} \[SEM\] (form)103.22 \[2.55\]102.23 \[3.61\]111.6 \[2.61\]IQ estimate \[SEM\] (motion)98.26 \[2.48\]104.01 \[4.57\]108.87 \[3.50\]Chlorpromazine dose \[mg\] \[SEM\] (form)569.93 \[65.68\]404.09 \[66.58\]--Chlorpromazine dose \[mg\] \[SEM\] (motion)552.25 \[97.65\]364.00 \[55.64\]Benzodiazepine dose \[mg\] \[SEM\] (form)19.89 \[7.31\]15.45 \[5.11\]--Benzodiazepine dose \[mg\] \[SEM\] (motion)19.11 \[8.17\]17.5 \[6.75\]DOI[f](#tf0035){ref-type="table-fn"} \[days\] \[SEM\] (form)4168.8 \[684.31\]3620.82 \[1107.83\]--DOI \[days\] \[SEM\] (motion)4420.89 \[942.85\]3563.13 \[1003.33\][^2][^3][^4][^5][^6][^7][^8]

In the form perception task, participants reported the presence or absence of objects (faces or flowers; [Fig. 1](#f0005){ref-type="fig"}) in visual noise arrays ([@bb0125]). Stimuli were 12.3 × 12.3 cm 8-bit greyscale arrays, subtending 12.3 × 12.3° visual angle. Sensitivity was measured as *d′*, and response bias as *c* ([@bb0145], [@bb0150]).Fig. 1Schematic diagram of presentation sequence for a single trial during the form perception task. Participants were required to report whether a target object (either a face or a flower) was present in a visual array. 'Object absent' stimuli were noise arrays with a reciprocal amplitude to spatial frequency (1/f) structure, approximating visual statistics of natural scenes ([@bb0070]), filtered to contain one octave of frequencies centred on 2.4 c/°, 'Object present' stimuli were similar noise arrays with a percentage of pixels from an object image replacing noise pixels in a portion of the image prior to filtering. All stimuli were filtered and scaled similarly, thereby ensuring similar root-mean-square contrast in 'present' and 'absent' stimuli. Participants completed four blocks of 120 trials, each containing 60 'object present' and 60 'object absent' trials. Stimuli were presented for an extended period of time (1000 ms) and ease of detection was manipulated by systematically varying the percentage of visual noise in 'object present' arrays (equal numbers 55/57/60%, randomly intermixed). The location of the object within the noise was randomly assigned on each trial (equating approximately to a location within one of the 4 quadrants of the image). Participants were correctly informed that half of trials contained objects. Faces and flowers were presented in separate blocks, and participants were told prior to each block whether the block\'s target objects were faces or flowers. As a result of computer error, data for flower blocks were unavailable for one participant.

In the motion integration task, participants reported the direction of motion (left or right) of coherently moving 'signal' dots amongst randomly moving 'noise' dots ([@bb0115]). Stimuli were 9 × 9 cm visual displays subtending 9 × 9° visual angle, containing 300 black and white dots on a grey background ([Fig. 2](#f0010){ref-type="fig"}). Sensitivity was calculated as the inverse of coherence threshold.Fig. 2Motion integration task stimuli. Stimuli contain both signal dots, which move coherently, and noise dots, which move in random directions. Dots were 2 mm in diameter and moved with a velocity of 10 cm/s for 750 ms per trial. The percentage of signal dots in the array is defined as the motion coherence level. Participants completed two blocks consisting of 50 trials each. Motion coherence level was initially set at 100% and adjusted using the adaptive QUEST algorithm in order to determine 75% correct thresholds. At 100% coherence (A) all dots move in the same direction; at 50% coherence (B) half the dots move in coherently and half move in random directions. Here, signal dots are moving to the right. Participants fixated upon a white circle 5 mm in diameter and reported the direction of motion (left or right) of the coherently moving 'signal' dots.

Form and motion tasks were completed in separate sessions, with task order counterbalanced between participants. Participants were seated comfortably in a dimly lit room, using a chin rest 57 cm from the monitor. Participants verbally reported responses to a researcher, who entered responses into the testing computer. Prior to each task participants completed a practice block with accurate task feedback. No feedback was provided during testing.

In form detection, a 3 × 2 mixed-design ANOVA revealed no significant effect of diagnostic group (schizophrenia spectrum disorder, bipolar, control) on sensitivity, *F*(2,42) = 1.07, *p* = .35 ([Fig. 3a](#f0015){ref-type="fig"}). However, there was a main effect of image type, with poorer sensitivity for faces (M = 1.32, *SEM* = 0.07) than flowers (M = 1.46, *SEM* = 0.09), *F*(1,42) = 4.44, *p* \< .05, ŋ~p~^2^ = .10. However, the interaction between diagnostic group and image type was not significant, *F*(2,42) = 1.01, *p* = .37, indicating that this pattern was observed across all diagnostic groups and is therefore likely to reflect differences in stimulus properties (such as symmetry) rather than visual pathology. This is consistent with the view that schizophrenia is associated with extensive general visual impairments, rather than a specific face-processing deficit ([@bb0060]). A second 3 × 2 mixed-design ANOVA revealed a main effect of image type on response bias, *F*(1,42) = 7.07, *p* \< .05, with participants more likely to report seeing faces than flowers. However, there was no main effect of diagnostic group on response bias, *F*(2,42) = 0.23, *p* = .79, and no interaction between diagnosis and image type, *F*(2,42) = 1.87, *p* = .17.Fig. 3(A) Mean form perception sensitivity as a function of diagnostic group and image type. Sensitivity is a summary measure calculated across both face and flower stimuli. Error bars represent 95% confidence intervals. (B) Mean motion integration sensitivity as a function of diagnostic group. Error bars represent 95% confidence intervals. Data are presented on a logarithmic scale.

In motion integration, a Kruskal--Wallis test revealed significant differences in motion coherence sensitivity between the three diagnostic groups (schizophrenia spectrum disorder, bipolar, control) χ^2^(2,*n* = 57) = 33.93, *p* \< .001 ([Fig. 3b](#f0015){ref-type="fig"}). Post-hoc Mann--Whitney *U* tests with Bonferroni adjustment for multiple comparisons revealed that sensitivity was significantly poorer amongst both participants with schizophrenia spectrum disorder, *U* = 7, *p* \< .001, and bipolar, *U* = 26, *p* \< .001, relative to healthy control participants, but did not differ significantly between the two patient groups, *U* = 40, *p* = .28.

Multiple linear regression indicated that form and motion task performance were unrelated to possible confounds including medication dosage, IQ, or illness duration (all *p* \> .05).

In summary, the present study found that inpatients with schizophrenia spectrum disorder or bipolar diagnoses were impaired in global motion detection, but not naturalistic global form detection, relative to healthy controls. This is consistent with the finding that low-level visual form perception was intact amongst individuals with schizophrenia who displayed impaired global motion perception ([@bb0015]). However, our results are somewhat incongruous with past research demonstrating abnormal form processing in schizophrenia spectrum disorders ([@bb0030], [@bb0105]). This apparent inconsistency may be the result of different task demands in different studies of form processing in schizophrenia spectrum disorder. Rather than identification or discrimination of forms, the present study assessed the ability to detect forms embedded within visual noise. As such, the task may have assessed a relatively early stage of form processing, prior to integration of information into a coherent percept. It is the latter function which is thought to be particularly compromised in schizophrenia spectrum disorder, even where early stages of form processing are intact ([@bb0095], [@bb0155]).

The present study found for the first time that this pattern of differential visual dysfunction was also present in individuals with bipolar affective disorder, consistent with previous findings showing that across diagnoses, the presence or absence of psychotic symptoms gives a more parsimonious explanation of patterns of sensory impairment than diagnosis ([@bb0025]). However, although patterns of sensory impairment were similar between schizophrenia spectrum disorder and bipolar in the present study, previous research has shown that in other psychophysical tasks, these disorders are associated with distinct patterns of sensory deficits (e.g. [@bb0040]). Moreover, the bipolar sample in the present study was relatively small, and as such it is possible that meaningful differences in form detection between these disorders may become apparent in future studies involving larger patient numbers. In addition, whereas some previous research has observed lower IQs in schizophrenia spectrum disorder than bipolar affective disorder ([@bb0130]), the present study found no significant difference in IQ between these disorders; it is therefore unclear how our results will generalise to the wider patient population. Finally, we note that since variability in visual acuity within the normal range can account for significant differences in visual task performance ([@bb0100]), we cannot rule out subtle differences in acuity between diagnostic groups as a possible confound of results.

The results of the present study demonstrate that individuals with schizophrenia spectrum disorder and bipolar affective disorder display intact naturalistic form detection alongside impaired global motion processing. This pattern is of particular interest since a prominent theory proposes that the primate visual system is divided into ventral 'what' (or form) and dorsal 'where' (or motion) cortical pathways ([@bb0110]). One interpretation of our results is that individuals with schizophrenia spectrum disorder and bipolar affective disorder may be more impaired in functions subserved by the latter pathway. Such a deficit might be the product of an impairment of magnocellular relative to parvocellular signalling in schizophrenia ([@bb0015], [@bb0065]). However, we also note that this simple anatomy--behaviour link has been disputed ([@bb0140]), and it is also possible that a generalised processing deficit in schizophrenia and bipolar affective disorder may have more strongly affected performance on the motion than the form task ([@bb0035]). Alternatively, a dissociation between form and motion processing might result from a general deficit in sensory integration, since motion processing introduces an additional dimension (time) across which to judge context.
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[^1]: These authors contributed equally to the work.

[^2]: All inpatients completed the form task, and a subset of inpatients also completed the motion task. Two healthy control participants completed both form and motion tasks.

[^3]: Including 18 with schizophrenia, three with schizoaffective disorder, and one with schizophreniform psychosis.

[^4]: Including ten participants in a manic episode at time of testing, and one in a depressed episode.

[^5]: Including 12 with schizophrenia, one with schizoaffective disorder, and one with schizophreniform psychosis.

[^6]: Including seven participants in a manic episode at time of testing, and one in a depressed episode.

[^7]: Due to dyslexia or illiteracy, IQ estimates were not available for two individuals in the schizophrenia group. In addition, two healthy control participants did not complete the NART.

[^8]: Duration of illness (DoI), calculated as elapsed days from assignment of current diagnosis to day of testing for patients with more than one admission; for first episode patients DoI was calculated from the day of admission to day of testing.
